Zobrazeno 1 - 10
of 70
pro vyhledávání: '"C. D. Perchonock"'
Autor:
J F, Newton, K M, Straub, R H, Dewey, C D, Perchonock, M E, McCarthy, J G, Gleason, R K, Lynn
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 20(4)
A primary route of inactivation of leukotrienes and their receptor antagonists (LTRA) is metabolism by omega oxidation. SKF 102922 [5-(2-(8-phenyloctyl)phenyl)-4,6-dithianonanedioic acid] is a LTRA that was designed to be resistant to omega oxidation
Autor:
D. S. Eggleston, C. D. Perchonock
Publikováno v:
Acta Crystallographica Section C Crystal Structure Communications. 42:233-236
Autor:
J F, Newton, K M, Straub, R H, Dewey, C D, Perchonock, T B, Leonard, M E, McCarthy, J G, Gleason, R D, Eckardt
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 15(2)
In vivo experiments indicate that the major route of metabolism of SKF 102,081 [5-(2-dodecylphenyl)-4,6-dithianonanedioic acid] is via omega-oxidation and subsequent beta-oxidation. Therefore, in vitro experiments were designed to characterize the in
Autor:
C. D. PERCHONOCK, J. A. FINKELSTEIN
Publikováno v:
Chemischer Informationsdienst. 11
Autor:
C. D. PERCHONOCK, J. A. FINKELSTEIN, I. UZINSKAS, J. G. GLEASON, H. M. SARAU, L. B. CIESLINSKI
Publikováno v:
Chemischer Informationsdienst. 14
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 15(2)
Both leukotrienes and their receptor antagonists possess substantial pharmacologic activity in in vitro systems, but their duration of action in vivo is extremely short. The exact mechanism of rapid inactivation of these lipids is unknown, but is lik
Publikováno v:
Chemischer Informationsdienst. 8
Publikováno v:
Chemischer Informationsdienst. 9
Publikováno v:
Chemischer Informationsdienst. 11
Autor:
P E, Bender, C D, Perchonock, W G, Groves, R C, Smith, O D, Stringer, R, Sneed, J H, Schlosser, L S, Hostelley, B Y, Hwang, R Z, Eby, G, Konicki, P G, Lavanchy, J W, Wilson, B, Loev
Publikováno v:
Journal of medicinal chemistry. 26(9)
A series of 9H-xanthen-9-amines possessing a wide variety of nitrogen substituents at C-9 was prepared for evaluation of gastric antisecretory activity. These substituents included the acetamidine, imidate, pyrimidine, thiazoline, quinuclidine, 2-hyd